Gen-Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.25M Sell
13,313
-881
-6% -$205K 1.03% 18
2025
Q4
$2.94M Sell
14,194
-1,576
-10% -$312K 0.94% 19
2025
Q3
$2.92M Buy
15,770
+1,202
+8% +$206K 0.99% 16
2025
Q2
$2.23M Buy
14,568
+5
+0% +$769 0.86% 21
2025
Q1
$2.42M Buy
14,563
+956
+7% +$150K 1.01% 16
2024
Q4
$1.97M Buy
13,607
+468
+4% +$72.5K 0.85% 20
2024
Q3
$2.11M Sell
13,139
-96
-0.7% -$15.3K 0.92% 18
2024
Q2
$1.93M Buy
13,235
+1,217
+10% +$181K 0.93% 16
2024
Q1
$1.9M Buy
+12,018
New +$1.91M 0.94% 19

Other funds holding JNJ

Gen-Wealth Partners's JNJ Position: Q1 2026 in Review

Gen-Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 6.2% in Q1 2026, selling an estimated $205K and leaving 13,313 shares worth $3.25M. The position accounts for 1.03% of the portfolio, ranked #18.

Gen-Wealth Partners first reported a position in JNJ in Q1 2024 and has held it in 9 quarters since. 4,627 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Gen-Wealth Partners held 13,313 shares of Johnson & Johnson worth $3.25M as of Q1 2026.
  • Gen-Wealth Partners sold 881 Johnson & Johnson shares in Q1 2026, an estimated $205K.
  • Johnson & Johnson made up 1.03% of Gen-Wealth Partners's portfolio in Q1 2026, its #18 holding.
  • Gen-Wealth Partners first reported a position in Johnson & Johnson in Q1 2024 and has held it in 9 quarters since.
  • 4,627 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Gen-Wealth Partners's 13F filing for Q1 2026, filed 8 May 2026.